news_6

Oasis Addresses Tsuruha’s False and Misleading Statements and Urges Shareholders to Support the Appointment of Independent Outside Directors (Stock Code: 3391 JT)

*Tsuruha makes false and misleading statements throughout its response to Oasis’s proposals, including about its relationship with North Pacific Bank...

LOGO-30

Qihan Biotech Announces NMPA Approval of Investigational New Drug (IND) Application for QN-019a, a Multi-locus Gene-Editing Cell Therapy Product to treat CD19-positive B-Cell Lymphoma

HANGZHOU, China--(BUSINESS WIRE)--Hangzhou Qihan Biotech Co., Ltd. ("Qihan" or "Qihan Biotech" or "the Company"), an industry leader in applying multiplexable...